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ABSTRACT 
This study used periodic health examination (PHE) data from 134 outfield elite male football 
players, over 5 seasons (1st July 2013 to 19th May 2018). Univariable and multivariable 
logistic regression models were used to determine prognostic associations between 36 
variables and time-loss, lower extremity index indirect muscle injuries (I-IMIs). Non-linear 
associations were explored using fractional polynomials. During 317 participant-seasons, 138 
I-IMIs were recorded. Univariable associations were determined for previous calf indirect 
muscle injury (IMI) frequency (OR=1.80, 95% confidence interval (CI) = 1.09 to 2.97), 
hamstring IMI frequency (OR=1.56, 95% CI=1.17 to 2.09), if the most recent hamstring IMI 
occurred > 12 months but < 3 years prior to PHE (OR= 2.95, 95% CI = 1.51 to 5.73) and age 
(OR =1.12 per 1-year increase, 95% CI = 1.06 to 1.18). Multivariable analyses demonstrated 
that if a player’s most recent previous hamstring IMI was >12 months but <3 years prior to 
PHE (OR= 2.24, 95% CI = 1.11 to 4.53), then this was the only variable with added 
prognostic value over and above age (OR=1.12 per 1-year increase, 95%CI = 1.05 to 1.18). 
Allowing non-linear associations conferred no advantage over linear ones. Therefore, PHE 
has limited use for injury risk prediction.  
 
Trial registration number = NCT03782389 
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INTRODUCTION 
Periodic health examination (PHE), or screening, is a well-established clinical evaluation 
strategy in elite football.1 Typically during PHE, players undertake various medical, 
musculoskeletal, functional and performance tests2 during preseason and in-season periods.1 
PHE allows opportunities for general health surveillance, identification of salient pathology3 
and monitoring of rehabilitation or performance.4 PHE is also assumed to have an important 
role in the development of injury prevention strategies.5 6 In particular, although PHE cannot 
establish specific causal factors for injuries,4 it is perceived to be useful for the prediction of 
future injury risk in athletes,2 4 where accurate predictions could help to identify individuals 
who may require interventions that are designed to reduce risk.7  
 
To make such predictions, prognostic factors are required which, in the context of football, 
could be any variables, characteristics or measurements available at or derived from PHE 
(e.g. medical history, leg strength or range of motion tests) that are associated with increased 
injury risk.4 The predictive power of a single prognostic factor is usually limited on its own.8 
9 However, if several prognostic factors are used in combination within a multivariable 
prognostic model, it may be possible to produce useful individualised risk estimates.8 10  
 
Because the predictive function of PHE remains unsubstantiated3 11 and given that indirect 
(non-contact) muscle injuries (IMIs) are a significant problem observed in elite football 
(accounting for 30.3% to 47.9% of all injuries),12-16 we have recently developed and 
internally validated a multivariable prognostic model to predict individualised lower 
extremity IMI risk in elite players using PHE data.17 However, sample size limitations meant 
that only 10 candidate prognostic factors could be considered in our model and these were 
selected using data quality assessment, clinical reasoning, or on the basis of our related 
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systematic review.11 The performance of our model was modest and we concluded that its use 
would not be beneficial in clinical practice.17  
 
Furthermore, our previous systematic review also highlighted several methodological 
limitations of the current evidence, which specifically included inadequate reporting of 
outcomes, prognostic factor measurement and reliability.11 Additionally, while most studies 
performed appropriate statistical analyses, continuous prognostic factor measurements were 
often categorised18-21 and non-linear associations were not investigated,18-24 which does not 
conform to current methodological recommendations.25-27  
 
To assist the development of future prognostic models, there is a clear need to ascertain the 
existence of robust and novel prognostic factors that have an association with IMIs.17 
Therefore, using routinely collected data from a 5-season period, we conducted an 
exploratory cohort study to examine: 1) prognostic associations between PHE-derived 
variables and IMI outcomes in elite footballers, using a wider set of candidates than had 
previously been considered17 and; 2) the prognostic value of these PHE-derived variables 
over and above standard anthropometric variables of age (which has previously confirmed 
prognostic value11 17), height and weight. In particular, both linear and non-linear associations 
between candidate variables and outcomes were explored which, to the best of our 




The methodology has been described in a published protocol28 so will only be briefly 
outlined. This study was registered on ClinicalTrials.gov (NCT03782389) and was reported 
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according to the Reporting Recommendations for Marker Prognostic Studies (REMARK).29 
Given the number of PHE-related variables examined, our study should be viewed as 
exploratory, but we emphasise that this an important phase in prognostic factor research.9 30  
 
Data Sources  
This study was of retrospective cohort design. Eligible participants were identified from a 
population of male elite footballers, aged 16-40 years old at Manchester United Football 
Club. A database was created using routinely collected injury records and preseason PHE 
data over 5 seasons (1st July 2013 to 19th May 2018). For each season (which started on 1st 
July), participants completed a mandatory PHE during the first week of the season and were 
followed up to the last first team game of the season.  
 
The PHE process typically included: 1) anthropometric measurements; 2) a review of 
medical and previous injury history; 3) musculoskeletal examination tests; 4) functional 
movement and balance tests; 5) strength and power tests. The PHE test order was self-
selected by each player and a standardised warm up was not implemented, although players 
could undertake their own warm up procedures if they wished. Each component of PHE was 
standardised according to a written protocol and was examined by physiotherapists, sports 
scientists or club medical doctors. The same examiners performed the same test every season 
to eliminate inter-tester variability. No examiner attrition occurred throughout the data 
collection period. If a participant was injured at the scheduled time of PHE, a risk assessment 
was completed by medical staff and participants only completed tests that were deemed 
appropriate and safe for the participant’s condition; examiners were therefore not blinded to 
injury status.  
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Eligibility criteria 
During any season, participants were eligible if they: 1) were not a goalkeeper; 2) 
participated in PHE for the relevant season. Participants were excluded if they were not under 
contract to the Club at the time of PHE.  
 
Ethics and Data Use 
Informed consent was not required as data were captured from the mandatory PHE completed 
through the participants’ employment. The data usage was approved by the Club and the 
Research Ethics Service at the University of Manchester. 
 
Participant involvement 
Participants were not involved in the study design. 
 
Outcome 
The outcome was any time-loss, index lower extremity IMI (I-IMI) sustained by a participant 
during match play or training, which affected any lower abdominal, hip, thigh, calf or foot 
muscle groups and prohibited future match or training participation.31  I-IMIs were confirmed 
and graded by a club doctor or physiotherapist according to the previously validated Munich 
Consensus Statement for the Classification of Muscle Injuries in Sport,32 33 during routine 
assessments undertaken within 24h of injury occurrence. The medical professionals were not 
blinded to PHE data at diagnosis.  
 
Sample size  
Our sample size of 317 participant-seasons (with 138 I-IMI events) had 80% power to detect 
an adjusted odds ratio (OR) of at least 1.6 for a 1 standard deviation increase in a variable of 
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interest, conservatively assuming a correlation of 0.5 with the adjustment variables of age, 
height and weight (see supplementary file 1 for the sample size calculation).34  
 
 
PHE-derived Candidate Variables   
The dataset contained 60 variables28 that were eligible for analysis unless there were >15% 
missing observations or if reliability (where applicable) was reported as fair to poor (that is, 
Intraclass Correlation Coefficient (ICC) < 0.70).28 35 If any variables did not meet these 
eligibility criteria, they were excluded (supplementary file 2). Collinearity between eligible 
variables was assessed with a scatterplot matrix; this was evident when tests were used to 
measure right and left limbs independently.28 In these circumstances, composite variables 
were created for between-limb differences and the mean of the test measurements for both 
limbs, as described in the study protocol.28 
 
 Of the remaining eligible variables, 10 were used in our multivariable prognostic model 
study (represented by 12 parameters).17 With the exception of age at PHE (which was used 
for adjustment purposes in this study), these candidates were therefore excluded.28 The final 
number of candidate variables included for exploratory analysis was 36. Table 1 summarises 
all included variables with their measurement units and data type, as well as the methods and 









 . CC-BY-NC-ND 4.0 International licenseIt is made available under a 
perpetuity. 
 is the author/funder, who has granted medRxiv a license to display the preprint in(which was not certified by peer review)preprint 
The copyright holder for thisthis version posted January 15, 2021. ; https://doi.org/10.1101/2021.01.15.21249653doi: medRxiv preprint 
 8 
Table 1: List of candidate variables with a summary of the units of measurement, methods and reliability of measurement and data type. 
 

























1: Medical records;  
 
2: Standing height 
measure; 
 











4: foot/ankle injuries; 5: hip/groin 
injuries;  
6: knee injuries; 7: shoulder injuries;  
8: lumbar spine injuries;  
9: iliopsoas IMIs;  
10: hip adductor IMIs;  
11: hamstring IMIs;  
12: quadriceps IMIs;  
13: calf IMIs 
 










14: foot/ankle injury; 15: hip/groin 
injury;  
16: knee injury; 17: shoulder injury;  
18: lumbar spine injury;  
19: iliopsoas IMI;  
20: hip adductor IMI;  
21: hamstring IMI;  
22: quadriceps IMI;  
23: calf IMI 
 
14-23:  
Never, < 6 
months, 6-12 
months, > 12 
months 





 24: Mean PROM hip internal rotation 
(IR); 
25: Mean PROM hip external rotation 
(ER); 
26: Mean hip flexor length; 
27: Mean hamstring length/neural 
mobility;  
28: Mean calf muscle length 
24-28:  Degrees 24-25: Digital 
inclinometer + ROM; 
 
26: Digital inclinometer 
+ Thomas Test; 
 
27: Digital inclinometer 
+ SLR; 
 





26: Inter-rater ICC = 
0.89;37 
 
27: Intra-rater ICC = 
0.95-0.98;38 
Inter-rater ICC = 
0.80-0.97;38 
 
28:  Inter-rater ICC = 
0.80- 0.95;39 40 





 29: Max. leg extension power 
difference;  
30: Mean of max. leg extension power;  
31: Max. leg extension velocity 
difference;  
32:  Mean of max. leg extension 
velocity;  
33: Max leg extension force difference;  
34: Mean of max. leg extension force;  
35: CMJ Force per kg of body mass;  
36:  CMJ height 
29-30: 
Normalised 
watts per kilo 
(W/kg-0.67); 
 














29-34: Double leg press 





(CMJ) + force plate 
29-30: Test-retest 
ICC = 0.886;41 
 
31-32:  Test-retest 
ICC = 0.792;41 
 
33-34: Test-retest 
ICC = 0.914;41 
 
35-36: Test-retest 
ICC = 0.80-0.88.42 
Cont. 
 
Key: I-IMI= index indirect muscle injury; grp=group; WBL=weight bearing lunge; CMJ=countermovement jump; PROM=passive range of 
movement; deg. = degrees; SLR= straight leg raise; BMI= body mass index; kg/m2 = kilograms/body height squared; W= watts (note: 
W/kg-0.67 has a scaling factor to normalise force to body mass 43); N= newtons (note: N/kg-0.67 has a scaling factor to normalise force to body 
mass 43);max.=maximum; m.s.= metres per second; cm = centimetres; Kg=kilograms; Cont.=continuous; dis./cont.= discrete treated as 
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Statistical analysis  
Data handling – outcome measures 
Each participant-season was treated as independent. If an I-IMI occurred, the participant’s 
outcome was determined for that season and they were no longer considered at risk. In these 
circumstances, participants were included for further analysis at the start of the consecutive 
season, if still eligible. Any upper limb IMI, trunk IMI or non-IMI injuries were ignored and 
participants were still considered at risk.  
 
Eligible participants who were loaned to another club throughout that season, but had not 
sustained an I-IMI prior to the loan were still considered at risk.  I-IMIs that occurred whilst 
on loan were included for analysis. Permanently transferred participants (who had not 
sustained an I-IMI prior to the transfer), were recorded as not having an I-IMI during the 
relevant season and exited the cohort at the season end.  
 
Data Handling – Missing data 
Missing values were assumed to be missing at random (i.e. missingness could be predicted 
conditional on other known variables).28 The continuous parameters generally demonstrated 
non-normal distributions, so were transformed using normal scores44 to approximate 
normality before imputation, and back-transformed following imputation.45 Multivariate 
normal multiple imputation was performed, using a model that included all candidate 
variables and I-IMI outcomes. Fifty imputed datasets were created in Stata 15.1 (StataCorp 
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Univariable and multivariable analyses 
All data were analysed in the form that they were recorded. In particular, variables that were 
recorded as continuous were kept continuous and not categorised, to avoid a loss of 
prognostic information.25 Univariable logistic regression models were used to estimate the 
unadjusted linear associations between I-IMIs and each candidate variable. Multivariable 
logistic regression models were also used to estimate the linear association between I-IMIs 
and each variable, after adjustment for age (which has confirmed prognostic importance11 17), 
height and weight (which were both considered as potential confounders for I-IMIs and PHE-
derived candidates). All parameter estimates were averaged across all imputed datasets using 
Rubin’s Rules46 and were computed using the ‘mim’ module in Stata 15.1. Statistical 
significance thresholds were used to indicate the strength of exploratory evidence against null 
associations, where p-values of : 1) <0.05 indicated strong evidence and the factor was 
considered significant; 2) 0.05 to 0.10 indicated weak evidence and; 3) >0.10 indicated little 
or no evidence.47 Prognostic importance was also considered by checking the magnitude of 
prognostic effects encompassed by the width of 95% confidence intervals. 
 
For all variables, non-linear associations with the outcome were also explored using 
fractional polynomials for the univariable and multivariable models; the fit of first and 
second order fractional polynomial models were evaluated against the fit of the standard 
logistic regression models.48  The parameter estimates were combined across all imputed 
datasets49 using Rubins Rules,46 with the automated ‘mfpmi’ algorithm in Stata 15.1, using a 
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Table 2: Summary of all statistical analyses performed 
 




IMIs Variables considered Adjusted for: Results 
Primary analysis, imputed data      
A1: Univariable Logistic Regression/FPs 317 138 Individual models for I-IMI + each variable (1-36) None Table 4 
A2: Multivariable Logistic Regression/FPs 317 138 Individual models for I-IMI + each variable (4-36) 
Variables 1-3 (age, 
height, weight) Table 4 
Primary analysis, complete case data      
B1: Univariable Logistic Regression/FPs 265 115 Individual models for I-IMI + each variable (1-36) None SF 5 
B2: Multivariable Logistic Regression/FPs 265 115 Individual models for I-IMI + each variable (4-36) 
Variables 1-3 (age, 
height, weight) SF 5 
Sensitivity analysis, imputed data      
C1: Univariable Logistic Regression/FPs 260 129 Individual models for I-IMI + each variable (1-36) None SF 6 
C2: Multivariable Logistic Regression/FPs 260 129 Individual models for I-IMI + each variable (4-36) 
Variables 1-3 (age, 
height, weight) SF 6 
Sensitivity analysis, complete case data      
D1: Univariable Logistic Regression/FPs 217 106 Individual models for I-IMI + each variable (1-36) None SF 7 
D2: Multivariable Logistic Regression/FPs 217 106 Individual models for I-IMI + each variable (4-36) 
Variables 1-3 (age, 
height, weight) SF 7 
Key: I-IMI= index indirect muscle injury; FP= fractional polynomials; SF= supplementary file  
 
Primary and sensitivity analyses  
To determine the effect of imputation and player transfers on variable associations, the 
analyses were repeated: 1) as complete cases analyses; and 2) as sensitivity analyses 
excluding participant-seasons for participants who were loaned or transferred (performed as 
both multiple imputation and complete case analyses). All primary complete case and 




During the five seasons, 134 participants were included, contributing 317 participant-seasons 
and 138 IMIs in the primary analysis (Figure 1). Three players were classified as injured at 
the time of PHE (which affected three participant-seasons). This meant they were unavailable 
for selection for training or matches at that time. However, these players had commenced 
football specific, field-based rehabilitation so also had similar exposure to training activities 
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to uninjured players and were therefore included in the cohort because it was reasonable to 
assume that they could also be considered at risk of an I-IMI event.  
 
For the sensitivity analyses (excluding loans and transfers), 260 independent participant-
seasons with 129 IMIs were included; 36 participants were transferred on loan, while 14 
participants were permanently transferred during a season, which excluded 57 participant-
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Figure 1: Participant flow chart 
 
 
Key: n=number of participants; I-IMI=index indirect muscle injury 
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Table 3 summarises the participant characteristics and candidate variable values for 
participants included in the primary analyses. All values were similar to those included in the 
sensitivity analyses (supplementary file 3). 
 
Missing data and multiple imputation  
Data were complete for age and all past medical history variables (Table 3). For all other 
candidates, the proportion of missing data ranged from 5.68% (for height and weight) to 
14.20% (for the mean and between limb differences of maximal leg extension power and 
force) (Table 3). For all continuous variables, the distribution of imputed values 
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Table 3. Characteristics of included participants 
Characteristics/candidate variables   Min Lower quartile Median 
Upper 
quartile Max. 
Freq. (%) - if 
categorical 
Missing 
values n (%) 
Anthropometrics          
1. Age at PHE (years)   16.01 17.80 19.69 23.56 39.59 - 0 (0) 
2. Height (cm)   164.3 176.0 180.0 185.5 195.0 - 18 (5.68) 
3. Weight (kg)   56.8 69.2 73.6 80.0 94.0 - 18 (5.68) 
Past medical history          
Within 3 years prior to PHE, freq. of:          
4. foot/ankle injuries   0 0 1 2 7 - 0 (0) 
5. Hip/groin injuries   0 0 0 1 5 - 0 (0) 
6. Knee injuries   0 0 0 1 3 - 0 (0) 
7. Shoulder injuries   0 0 0 0 2 - 0 (0) 
8. lumbar spine injuries   0 0 0 0 3 - 0 (0) 
9. iliopsoas IMIs   0 0 0 0 2 - 0 (0) 
10. hip adductor IMIs   0 0 0 0 3 - 0 (0) 
11.hamstring IMIs   0 0 0 1 6 - 0 (0) 
12. quadriceps IMIs   0 0 0 0 3 - 0 (0) 
13. calf IMIs   0 0 0 0 4 - 0 (0) 
Within 3 years prior to PHE, most recent:           
14. foot/ankle injury Never - - - - - 143 (45.11) 0 (0) 
 < 6 months - - - - - 43 (13.56) 0 (0) 
  6-12 months - - - - - 34 (10.73) 0 (0) 
  >12 months - - - - - 97 (30.60) 0 (0) 
15. Hip/groin injury Never - - - - - 217 (68.45) 0 (0) 
 < 6 months - - - - - 23 (7.26) 0 (0) 
  6-12 months - - - - - 23 (7.26) 0 (0) 
  >12 months - - - - - 54 (17.03) 0 (0) 
16. Knee injury Never - - - - - 201 (63.41) 0 (0) 
 < 6 months - - - - - 15 (4.73) 0 (0) 
  6-12 months - - - - - 31 (9.78) 0 (0) 
  >12 months - - - - - 70 (22.08) 0 (0) 
17. Shoulder injury Never - - - - - 297 (93.69) 0 (0) 
 < 6 months - - - - - 6 (1.89) 0 (0) 
  6-12 months - - - - - 4 (1.26) 0 (0) 
  >12 months - - - - - 10 (3.15) 0 (0) 
18. lumbar spine injury Never - - - - - 264 (83.28) 0 (0) 
 < 6 months - - - - - 8 (2.52) 0 (0) 
  6-12 months - - - - - 9 (2.84) 0 (0) 
  >12 months - - - - - 36 (11.36) 0 (0) 
19. iliopsoas IMI Never - - - - - 287 (90.54) 0 (0) 
 < 6 months - - - - - 2 (0.63) 0 (0) 
  6-12 months - - - - - 9 (2.84) 0 (0) 
  >12 months - - - - - 19 (5.99) 0 (0) 
20. hip adductor IMI Never - - - - - 263 (82.92) 0 (0) 
 < 6 months - - - - - 18 (5.68) 0 (0) 
  6-12 months - - - - - 12 (3.79) 0 (0) 
  >12 months - - - - - 24 (7.57) 0 (0) 
21.hamstring IMI Never - - - - - 231 (72.87) 0 (0) 
 < 6 months - - - - - 11 (3.47) 0 (0) 
  6-12 months - - - - - 30(9.46) 0 (0) 
  >12 months - - - - - 45 (14.20) 0 (0) 
22. quadriceps IMI Never - - - - - 267 (84.23) 0 (0) 
 < 6 months - - - - - 7 (2.21) 0 (0) 
  6-12 months - - - - - 13 (4.10) 0 (0) 
  >12 months - - - - - 30 (9.46) 0 (0) 
23. calf IMI Never - - - - - 283 (89.27) 0 (0) 
 < 6 months - - - - - 11 (3.47) 0 (0) 
  6-12 months - - - - - 6 (1.89) 0 (0) 
  >12 months - - - - - 17 (5.36) 0 (0) 
Musculoskeletal Examination          
24. Mean PROM hip IR (deg.)   9.5 22.5 33.0 40.0 55.0 - 20 (6.31) 
25. Mean PROM hip ER (deg.)   17.5 33.5 38.5 43.0 62.0 - 20 (6.31) 
26. Mean hip flexor length (deg.)   -7.0 3.5 9.0 15.0 55.0 - 23 (7.26) 
27. Mean hamstring/neural mobility length 
(deg.)   45.0 84.0 90.0 90.0 102.0 - 20 (6.31) 
28. Mean calf muscle length (deg.)   9.5 25.0 30.0 36.0 57.5 - 20 (6.31) 
Strength/Power Tests          
29: Max. leg extension power difference 
(W/kg-0.67)   -11.94 -1.55 0.29 1.77 15.26 - 45 (14.20) 
30: Mean of max. leg extension power 
(W/kg-0.67)   23.01 42.12 46.52 51.95 78.69 - 45 (14.20) 
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31: Max. leg extension velocity difference 
(m.s -1)   -0.34 -0.05 0.02 0.11 0.40 - 41 (12.93) 
32:  Mean of max. leg extension velocity 
(m.s -1)   1.02 1.68 1.84 1.98 2.35 - 41 (12.93) 
33: Max leg extension force difference 
(N/kg-0.67) 
 
-83.59 -6.18 1.17 4.40 55.41 - 45 (14.20) 
34: Mean of max. leg extension force (N/kg-
0.67)   50.19 98.59 101.44 113.44 217.95 - 45 (14.20) 
35: CMJ Force per kg of body mass   20.20 23.40 25.40 28.04 39.20 - 42 (13.25) 
36:  CMJ height (cm)   28.7 37.3 40.2 43.0 58.0 - 42 (13.25) 
 
Key: PHE= periodic health examination; I-IMI=index indirect muscle injury; IMI= indirect muscle injury; IQR= interquartile range; n = observations; Freq= frequency; WBL=weight 
bearing lunge; CMJ=countermovement jump; PROM=passive range of movement; deg. = degrees; SLR= straight leg raise; BMI= body mass index; kg/m2 = kilograms/body height 
(metres) squared; cm = centimetres; Kg=kilograms; W= watts (note: W/kg-0.67 has a scaling factor to normalise force to body mass43); N= newtons (note: N/kg-0.67 has a scaling factor to 
normalise force to body mass43);max.=maximum; m.s.= metres per second; cm = centimetres; Kg=kilograms; - = not applicable. Note that for the Musculoskeletal Examination and 
Strength/Power factors, positive values indicate greater left limb values compared to right limb values; negative values indicate greater right limb values compared to left limb values.   
 
Univariable analyses  
Table 4 shows the results of the univariable analyses. The continuous variables of age (OR= 
1.12 for a 1-year increase, 95% confidence interval (CI)=1.06 to 1.18, p<0.001), weight 
(OR=1.03 for a 1kg increase, 95% CI=1.00 to 1.07, p=0.03) and mean hip IR PROM (OR= 
0.97 for a 1-degree increase, 95% CI = 0.95 to 0.99, p=0.01) showed a significant but modest 
association with I-IMIs. The narrow CIs indicated that these estimates were relatively 
precise. Linear associations were the best fit for all these continuous variables. Significant 
associations with larger OR estimates were observed for previous calf IMI frequency 
(OR=1.80, 95% CI = 1.09 to 2.97, p=0.02), hamstring IMI frequency (OR=1.56, 95% 
CI=1.17 to 2.09, p<0.001), and if the most recent hamstring IMI occurred more than 12 
months but less than 3 years prior to PHE (OR= 2.95, 95% CI = 1.51 to 5.73, p<0.001). The 
wider CIs for these estimates indicated greater imprecision about the prognostic effect; this 
may because these candidates were either discrete or categorical, rather than continuous.   
 
Despite relatively large ORs, weaker evidence of associations was observed for the frequency 
of previous shoulder injuries (OR=2.38, 95% CI = 0.98 to 5.75, p=0.05) and if the most 
recent calf IMI was less than 6 months prior to PHE (OR=3.78, 95% CI=0.98 to 14.56, 
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p=0.05). However, the very wide CIs indicated considerable uncertainty about the true OR. 
No other significant candidate factors were observed. 
 
Multivariable analyses 
Table 4 shows the results of the multivariable analyses, where the adjusted prognostic value 
was evaluated for all PHE-derived variables. After adjustment for height and weight, age 
remained significantly associated with increased odds of sustaining an I-IMI during a season 
(OR=1.12 for a 1-year increase, 95%CI = 1.05 to 1.18, p<0.001) and a linear association was 
the best fit for this variable. However, there was no evidence that height and weight were 
strong prognostic factors independent of age. 
 
After adjustment for age, height and weight, if the most recent hamstring IMI was more than 
12 months but less than 3 years prior to PHE, the significant association and wide CI also 
remained (OR= 2.24, 95% CI = 1.11 to 4.53, p=0.02). However, no other candidates 
demonstrated prognostic importance. For most variables, the magnitude of the adjusted 
prognostic association was also smaller than the unadjusted association and some confidence 
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Table 4:  Univariable and multivariable logistic regression estimates for all candidate prognostic factors 
 Univariable (unadjusted) Multivariable (adjusted for age, height, weight) 
Candidate PF & Type OR  95% CI P Best model fit OR  95% CI P 
Best model 
fit 
Anthropometric (Adjustment Factors):          
1: Age (years)  1.12 1.06-1.18 <0.001 Linear 1.12 1.05 to 1.18 <0.001 Linear 
2: Height (cm) 1.03 0.99 to 1.07 0.13 - 1.02 0.97 to 1.07 0.46 - 
3: Weight (kg) 1.03 1.00 to 1.07 0.03 Linear 1.00 0.95 to 1.04 0.91 - 
Within 3 years preceding PHE, frequency of:          
4: foot/ankle injuries  1.04 0.87 to 1.24 0.68 - 1.04 0.87 to 1.25 0.65 - 
5: hip/groin injuries 1.16 0.90 to 1.51 0.25 - 1.29 0.99 to 1.70 0.06 - 
6: knee injuries 0.96 0.72 to 1.29 0.81 - 0.98 0.72 to 1.32 0.88 - 
7: shoulder injuries 2.38 0.98 to 5.75 0.05 - 1.89 0.76 to 4.74 0.17 - 
8: lumbar spine injuries 0.88 0.60 to 1.29 0.50 - 1.08 0.72 to 1.61  0.71 - 
9: iliopsoas IMIs 0.73 0.38 to 1.43 0.37 - 0.86 0.43 to 1.71 0.67 - 
10: hip adductor IMIs 1.38 0.92 to 2.09 0.12 - 1.18 0.76 to 1.84 0.46 - 
11: hamstring IMIs 1.56 1.17 to 2.09 <0.001 Linear 1.35 1.00 to 1.83 0.05 - 
12: quadriceps IMIs 1.08 0.67 to 1.73 0.75 - 1.05 0.65 to 1.71 0.84 - 
13: calf IMIs 1.80 1.09 to 2.97 0.02 Linear 1.30 0.75 to 2.25 0.35 - 
Within 3 years preceding PHE, most recent:          
14: foot/ankle injury (never)  ref ref ref - ref ref ref - 
14: foot/ankle injury (<6 months)  1.27 0.64 to 2.53 0.49 - 1.41 0.69 to 2.87 0.35 - 
14: foot/ankle injury (6-12 months) 1.16 0.54 to 2.46 0.71 - 1.15 0.52 to 2.52 0.73 - 
14: foot/ankle injury (>12 months) 1.27 0.75 to 2.13 0.37 - 1.22 0.71 to 2.09 0.47 - 
15: hip/groin injury (never) ref ref ref - ref ref ref - 
15: hip/groin injury (<6 months) 1.05 0.44 to 2.49 0.92 - 1.66 0.67 to 4.13 0.27 - 
15: hip/groin injury (6-12 months) 0.59 0.23 to 1.50 0.27 - 0.65 0.25 to 1.69 0.38 - 
15: hip/groin injury (>12months) 1.58 0.87 to 2.87 0.14 - 1.80 0.96 to 3.36 0.07 - 
16: knee injury (never) ref ref ref - ref ref ref - 
16: knee injury (<6 months) 1.15 0.40 to 3.28 0.80 - 1.12 0.37 to 3.34 0.84 - 
16: knee injury (6-12 months) 1.23 0.58 to 2.62 0.60 - 1.24 0.57 to 2.70 0.60 - 
16: knee injury (>12months) 0.93 0.53 to 1.61 0.79 - 0.99 0.56 to 1.75 0.96 - 
17: shoulder injury (never) ref ref ref - ref ref ref - 
17: shoulder injury (<6 months) 2.75 0.50 to 15.26 0.25 - 2.55 
0.44 to 
14.72 0.30 - 
17: shoulder injury (6-12 months) 1.38 0.19 to 9.90 0.75 - 1.11 1.15 to 8.36 0.92 - 
17: shoulder injury (>12months) 3.21 0.81 to 12.67 0.10 - 2.36 0.58 to 9.62 0.23 - 
18: lumbar spine injury (never)  ref ref ref - ref ref ref - 
18: lumbar spine injury (<6 months)  1.24 0.30 to 5.05 0.77 - 2.10 0.50 to 8.82 0.31 - 
18: lumbar spine injury (6-12 months)  0.62 0.15 to 2.53 0.50 - 0.75 0.18 to 3.14 0.69 - 
18: lumbar spine injury (>12months) 0.70 0.34 to 1.44 0.33 - 0.97 0.46 to 2.06 0.94 - 
19: iliopsoas IMI (never)  ref ref ref - ref ref ref - 
19: iliopsoas IMI (<6 months)  1.24 0.77 to 20.05 0.88 - 1.27 
0.08 to 
21.32 0.87 - 
19: iliopsoas IMI (6-12 months) 0.62 0.15 to 2.53 0.51 - 0.83 0.20 to 3.43 0.80 - 
19: iliopsoas IMI (>12months) 0.57 0.21 to 1.55 0.27 - 0.66 0.24 to 1.82 0.42 - 
20: hip adductor IMI (never) ref ref ref - ref ref ref - 
20: hip adductor IMI (<6 months) 1.37 0.53 to 3.56 0.52 - 1.29 0.48 to 3.47 0.61  
20: hip adductor IMI (6-12 months) 1.37 0.43 to 4.36 0.60 - 1.16 0.35 to 3.81 0.81 - 
20: hip adductor IMI (>12months) 1.37 0.59 to 3.16 0.46 - 1.14 0.47 to 2.79 0.77 - 
21: hamstring IMI (never) ref ref ref - ref ref ref - 
21: hamstring IMI (<6 months) 2.84 0.81 to 9.99 0.10 - 2.07 0.57 to 7.56 0.27 - 
21: hamstring IMI (6-12 months) 1.42 0.66 to 3.06 0.37 - 1.22 0.56 to 2.70 0.62 - 
21: hamstring IMI (>12months) 2.95 1.51 to 5.73 <0.001 Linear 2.24 1.11 to 4.53 0.02 Linear 
22: quadriceps IMI (never) ref ref ref - ref ref ref - 
22: quadriceps IMI (<6 months) 1.74 0.38 to 7.91 0.48 - 1.56 0.33 to 7.36 0.58 - 
22: quadriceps IMI (6-12 months) 0.58 0.17 to 1.93 0.37 - 0.59 0.17 to 2.04 0.41 - 
22: quadriceps IMI (>12months) 1.14 0.53 o 2.43 0.74 - 1.07 0.49 to 2.35 0.86 - 
23: calf IMI (never) ref ref ref - ref ref ref - 
23: calf IMI (<6 months) 3.78 0.98 to 14.56 0.05 - 3.11 
0.78 to 
12.46 0.11 - 
23: calf IMI (6-12 months) 7.09 0.82 to 61.51 0.08 - 3.80 
0.41 to 
35.41 0.24 - 
23: calf IMI (>12months) 1.26 0.47 to 3.36 0.64 - 0.73 0.24 to 2.15 0.56 - 
Musculoskeletal:          
24. Mean PROM hip IR (deg.) 0.97 0.95 to 0.99 0.01 Linear 0.98 0.95 to 1.00 0.06 - 
25. Mean PROM hip ER (deg.) 0.97 0.95 to 1.00 0.09 - 0.99 0.96 to 1.02 0.53 - 
26. Mean hip flexor length (deg.) 1.01 0.98 to 1.04  0.46 - 1.01 0.99 to 1.04 0.32 - 
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27. Mean hamstring/neural mobility length (deg.) 0.99 0.96 to 1.02 0.53 - 0.98 0.95 to 1.02 0.33 - 
28. Mean calf muscle length (deg.) 1.00 0.97 to 1.02 0.77 - 1.00 0.97 to 1.02 0.79 - 
Strength/Power:          
29: Max. leg extension power difference (W/kg-0.67) 0.99 0.92 to 1.07 0.84 - 0.99 0.91 to 1.06 0.71 - 
30: Mean of max. leg extension power (W/kg-0.67) 1.02 0.99 to 1.05 0.24 - 1.01 0.97 to 1.04 0.73 - 
31: Max. leg extension velocity difference (m.s -1) 2.15 0.31 to 14.88 0.44 - 2.83 
0.38 to 
21.31 0.31 - 
32:  Mean of max. leg extension velocity (m.s -1) 1.96 0.68 to 5.64 0.21 - 1.48 0.49 to 4.47 0.49 - 
33: Max leg extension force difference (N/kg-0.67) 0.99 0.98 to 1.02 0.76 - 1.00 0.98 to 1.02 0.65 - 
34: Mean of max. leg extension force (N/kg-0.67) 1.00 0.99 to 1.01 1.00 - 1.00 0.99 to 1.01 0.72 - 
35: CMJ Force per kg of body mass (N/kg) 0.99 0.93 to 1.06 0.78 - 0.99 0.92 to 1.07 0.80 - 
36:  CMJ height (cm) 1.03 0.98 to 1.08 0.27 - 0.72 0.96 to 1.07 0.63 - 
Key: PHE= periodic health examination; PF= prognostic factor; OR=odds ratio; CI=confidence interval; ref=reference category;  I-IMI=index 
indirect muscle injury; IMI= indirect muscle injury; Freq= frequency; WBL=weight bearing lunge; CMJ=countermovement jump; PROM=passive 
range of movement; deg. = degrees; SLR= straight leg raise; BMI= body mass index; kg/m2 = kilograms/body height (metres) squared; cm = 
centimetres; Kg=kilograms; W= watts (note: W/kg-0.67 has a scaling factor to normalise force to body mass43); N= newtons (note: N/kg-0.67 has a 
scaling factor to normalise force to body mass43);max.=maximum; m.s.= metres per second; cm = centimetres; Kg=kilograms; - = not applicable.  
Note: ORs are expressed per one-unit increase for all continuous factors, and according to category for all categorical factors; Factors in bold 
indicate significance at the 0.05 level.  
 
 
Complete case and sensitivity analysis 
The results of all complete case and sensitivity analyses are presented in supplementary files 
5-7). Figures 2 and 3 show forest plots of the estimates obtained for all statistically 
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Figure 2: Comparison of candidate prognostic factors with significant associations across the primary and sensitivity univariable analyses 
(using imputed and complete case datasets). 
 
Key: OR = odds ratio; freq. = frequency; IMI = indirect muscle injury; PHE = periodic health examination; PROM = passive range of movement. 
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Figure 3: Comparison of candidate prognostic factors with significant associations across the primary and sensitivity multivariable analyses 
(using imputed and complete case datasets) 
 
Key: OR = odds ratio; freq. = frequency; IMI = indirect muscle injury; PHE = periodic health examination; PROM = passive range of movement. 
Note: the factor of age was adjusted for height and weight. All other factors were adjusted for age, height and weight. 
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For both univariable and multivariable analyses, the prognostic associations were very 
similar for the complete case and imputation analyses. Sensitivity analyses (that is, excluding 
players who were loaned or transferred) led to slightly stronger prognostic associations for 
some factors (for example, the frequency and timing of previous hamstring injuries), 
although the CIs were wider.   
 
DISCUSSION 
This exploratory study has examined linear and non-linear prognostic associations between 
PHE-derived variables and I-IMIs in elite football players, using routinely collected data 
from a 5-season period.  
 
While the univariable analyses suggested 6 candidate factors were associated with I-IMIs, 
such analyses are limited as they only provide baseline association measures prior to 
adjustment for other important prognostic factors.29 However, after adjustment for age, height 
and weight in the multivariable analyses, we found that most PHE derived variables did not 
add any prognostic value over and above age. The exception was that if a hamstring IMI was 
sustained by a player more than 12 months (but less than 3 years) prior to PHE, their odds of 
sustaining a lower extremity I-IMI significantly increased 2.2-fold, which has not been 
previously reported. Although not directly comparable, earlier studies have also shown that a 
history of a previous hamstring IMI is specifically associated with an increased hazard of 
future hamstring IMIs in elite players.11 20 22 Nevertheless, the uncertainty in our estimates 
(demonstrated by wide 95% confidence intervals) and differences observed during the 
sensitivity analyses mean that this variable only has provisional prognostic value and needs to 
be established in further confirmatory studies. 
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Indeed, age was the only variable that could be considered as an important prognostic factor, 
which is easily obtained even without conducting PHE; after allowing for height and weight, 
age retained a highly significant, modest and precise association that was robust to both 
imputation and player transfers. For illustration, our estimates suggest that for every 1-year 
increase in age, the odds of sustaining an I-IMI during a season would increase by 
approximately 12%. As an example (to put into the context of absolute risk), for two players 
who were the same height and weight but aged 5 years apart, if the younger-aged player had 
a risk of 0.44 (which was overall outcome prevalence in our study), then the older player 
would have a risk of 0.58. 
 
Our findings confirm those of our multivariable prognostic model study, where age was 
retained in a model to determine individualised I-IMI risk over a season in elite players (OR 
= 1.10, 95% CI = 1.03 to 1.17).17 Other studies have shown that as a multivariable prognostic 
factor, age is associated specifically with increased hamstring IMI risk (OR range 1.40-1.78), 
11 18 23 where the reported estimates were larger than those observed in our study. These 
differences may be due to chance or partly because we merged all lower extremity I-IMI 
outcomes rather than utilising IMI subgroups, which may have diluted the strength of our 
observed associations. However, although our approach was less clinically meaningful, 
merging I-IMI outcomes was essential in order to maximise the statistical power of our study.  
 
Importantly, while multiple exploratory studies have confirmed the prognostic importance of 
age,11 17 18 23 it is not a causal factor for future IMI occurrence. Rather, it is likely to be a 
proxy marker for another potential causal mechanism, although to establish the true causal 
role of a prognostic factor, associations should be demonstrated during additional 
confirmatory and explanatory studies.50 Even taking this into account, injury prevention 
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strategies have been traditionally developed to modify supposed causal factors,6 but because 
age is non-modifiable it could not be used to inform this process in a clinical setting. Instead, 
age should currently only be considered clinically useful to explain differences in risk 
between players in a team, or included as an important factor in future prognostic model 
development studies.  
 
Using data from PHE tests that measure modifiable physical and performance characteristics 
has been previously questioned for injury prediction purposes.2 Our results fully support this 
view, because none of the modifiable musculoskeletal (clinical examination) or strength and 
power tests evaluated showed any statistically significant associations with I-IMIs. This 
absence of strong associations mean that such tests have poor discriminatory ability, usually 
because of overlap in test scores that occur in individuals who sustain a future injury and 
those who do not.2 Furthermore, after measurement at a solitary timepoint (i.e. pre-season), it 
is likely that the prognostic value of modifiable factors is time-varying51 as a consequence of 
physical and physiological adaptations that occur from training exposure and other injuries.52  
 
Overall, our findings suggest that at present, PHE cannot be considered a useful source of 
prognostic factors for IMI risk prediction and injury prevention practice in elite football 
players. Instead, PHE should only be deemed clinically useful for screening of pathology that 
could pose a risk to safe participation and for rehabilitation or performance monitoring 
purposes. However, because of our study’s exploratory nature (with many estimates having 
very wide confidence intervals), the shortcomings of the current evidence base and the 
paucity of known prognostic factors in elite football,11 there is a clear need for further 
investigation in this area to improve our understanding of the prognostic value of PHE in elite 
football and other sports.   
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Limitations and future research 
Our study is unique in that we have investigated non-linear associations as per 
methodological guidelines.9 53 However, in our analyses linear associations were selected 
over non-linear associations. For practical reasons, our imputation did not assume non-linear 
associations and therefore may have reduced our ability to detect genuine non-linear 
relationships in the subsequent analyses. However, this is not a concern for age, as there were 
no missing values for this factor and is unlikely to be a material concern for all other factors 
as missing data was always less than 15%. 
 
A competing risks analysis was not conducted, which meant that individuals who sustained 
injury types other than lower extremity IMIs were still considered at risk, even though this 
may have affected their training and match exposure and hence risk of sustaining an I-IMI 
event. We also only measured candidate factors at one timepoint each season, which means 
that dynamic associations were not investigated. We also assumed that participant-seasons 
were independent. Future studies could account for competing risks, utilise repeated 
measurements over time and incorporate between-season correlations into analyses. 
However, the complexity such analyses would also require a significantly larger volume of 
data. This could be achieved through data sharing initiatives and individual participant data 
meta-analysis, which would also increase the power to detect genuine prognostic associations 
and non-linear relationships. 
 
CONCLUSION 
We have evaluated prognostic associations between PHE-derived candidate variables and 
lower extremity I-IMIs in elite football players using data that were routinely collected over 5 
seasons. We found no clear associations for nearly all PHE variables, although if a player 
 . CC-BY-NC-ND 4.0 International licenseIt is made available under a 
perpetuity. 
 is the author/funder, who has granted medRxiv a license to display the preprint in(which was not certified by peer review)preprint 
The copyright holder for thisthis version posted January 15, 2021. ; https://doi.org/10.1101/2021.01.15.21249653doi: medRxiv preprint 
 26 
sustained a hamstring IMI greater than 12 months (but less than 3 years) prior to PHE, then  
this had potential prognostic value over and above the prognostic value of age. Indeed, age 
was the only variable to be confirmed as a clear prognostic factor in both univariable and 
multivariable analyses. However, this is easily measured without then need to conduct PHE, 
and although it has limited application in clinical practice, it should be included as an 
important factor in any future prognostic model development studies. Our findings suggest 
that overall, PHE cannot be currently considered as a useful source of prognostic factors for 
I-IMI risk prediction and injury prevention practice in elite football players. Instead, it should 
only be utilised for screening of pathology, as well as rehabilitation and performance 
monitoring. Further research is required to confirm the prognostic value of PHE for IMI risk 
prediction and to identify novel prognostic factors that could improve development of 
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